Cortical iron regulation and inflammatory response in Alzheimer's disease and APPSWE/PS1ΔE9 mice: A histological perspective

Frontiers in Neuroscience

Volumn 9, Issue JUL, 2015, Pages

  Meadowcroft, Mark D ^a   Connor, James R ^a   Yang, Qing X ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Amyloid beta plaques; APP PS1; Astrocyte; Ferritin; Histology; Iron; Microglia

Indexed keywords

AMYLOID BETA PROTEIN ANTIBODY; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; FERRITIN; IRON; PRESENILIN 1; THIOFLAVINE;

AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; FEMALE; GLIOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; IRON TRANSPORT; MALE; MICROGLIA; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; SPECIES DIFFERENCE;

EID: 84938500229     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00255     Document Type: Article

References (82)

1. Atwood, C. S., Huang, X., Moir, R. D., Tanzi, R. E., and Bush, A. I. (1999). Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease. Met. Ions Biol. Syst. 36, 309-364.
2. Avramovich-Tirosh, Y., Amit, T., Bar-Am, O., Weinreb, O., and Youdim, M. B. (2008). Physiological and pathological aspects of Abeta in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators. BMC Neurosci. 9(Suppl. 2):S2. doi: 10.1186/1471-2202-9-S2-S2.
3. Ayton, S., Lei, P., and Bush, A. I. (2013). Metallostasis in Alzheimer's disease. Free Radic. Biol. Med. 62, 76-89. doi: 10.1016/j.freeradbiomed.2012.10.558.
4. Ayton, S., Zhang, M., Roberts, B. R., Lam, L. Q., Lind, M., McLean, C., et al. (2014). Ceruloplasmin and beta-amyloid precursor protein confer neuroprotection in traumatic brain injury and lower neuronal iron. Free Radic. Biol. Med. 69, 331-337. doi: 10.1016/j.freeradbiomed.2014.01.041.
5. Benveniste, E. N., Nguyen, V. T., and O'Keefe, G. M. (2001). Immunological aspects of microglia: relevance to Alzheimer's disease. Neurochem. Int. 39, 381-391. doi: 10.1016/S0197-0186(01)00045-6.
6. Bodovitz, S., Falduto, M. T., Frail, D. E., and Klein, W. L. (1995). Iron levels modulate alpha-secretase cleavage of amyloid precursor protein. J. Neurochem. 64, 307-315. doi: 10.1046/j.1471-4159.1995.64010307.x.
7. Borchelt, D. R., Davis, J., Fischer, M., Lee, M. K., Slunt, H. H., Ratovitsky, T., et al. (1996). A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet. Anal. 13, 159-163. doi: 10.1016/S1050-3862(96)00167-2.
8. Borchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., et al. (1997). Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939-945. doi: 10.1016/S0896-6273(00)80974-5.
9. Bourassa, M. W., Leskovjan, A. C., Tappero, R. V., Farquhar, E. R., Colton, C. A., Van Nostrand, W. E., et al. (2013). Elevated copper in the amyloid plaques and iron in the cortex are observed in mouse models of Alzheimer's disease that exhibit neurodegeneration. Biomed. Spectrosc. Imaging 2, 129-139. doi: 10.3233/BSI-130041.
10. Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., and Del Tredici, K. (2006). Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 112, 389-404. doi: 10.1007/s00401-006-0127-z.
11. Braak, H., and Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259. doi: 10.1007/BF00308809.
12. Bush, A. I. (2002). Metal complexing agents as therapies for Alzheimer's disease. Neurobiol. Aging 23, 1031-1038. doi: 10.1016/S0197-4580(02)00120-3.
13. Carlson, E. S., Magid, R., Petryk, A., and Georgieff, M. K. (2008). Iron deficiency alters expression of genes implicated in Alzheimer disease pathogenesis. Brain Res. 1237, 75-83. doi: 10.1016/j.brainres.2008.07.109.
14. Casas, C., Sergeant, N., Itier, J. M., Blanchard, V., Wirths, O., van der Kolk, N., et al. (2004). Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am. J. Pathol. 165, 1289-1300. doi: 10.1016/S0002-9440(10)63388-3.
15. Chamberlain, R., Wengenack, T. M., Poduslo, J. F., Garwood, M., and Jack, C. R. Jr. (2011). Magnetic resonance imaging of amyloid plaques in transgenic mouse models of Alzheimer's disease. Curr. Med. Imaging Rev. 7, 3-7. doi: 10.2174/157340511794653522.
16. Collingwood, J. F., Chong, R. K., Kasama, T., Cervera-Gontard, L., Dunin-Borkowski, R. E., Perry, G., et al. (2008). Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. J. Alzheimers. Dis. 14, 235-245.
17. Connor, J. R., Boeshore, K. L., Benkovic, S. A., and Menzies, S. L. (1994). Isoforms of ferritin have a specific cellular distribution in the brain. J. Neurosci. Res. 37, 461-465. doi: 10.1002/jnr.490370405.
18. Connor, J. R., and Fine, R. E. (1986). The distribution of transferrin immunoreactivity in the rat central nervous system. Brain Res. 368, 319-328. doi: 10.1016/0006-8993(86)90576-7.
19. Connor, J. R., and Fine, R. E. (1987). Development of transferrin-positive oligodendrocytes in the rat central nervous system. J. Neurosci. Res. 17, 51-59. doi: 10.1002/jnr.490170108.
20. Connor, J. R., Menzies, S. L., St Martin, S. M., and Mufson, E. J. (1990). Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J. Neurosci. Res. 27, 595-611. doi: 10.1002/jnr.490270421.
21. Connor, J. R., Menzies, S. L., St Martin, S. M., and Mufson, E. J. (1992b). A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J. Neurosci. Res. 31, 75-83. doi: 10.1002/jnr.490310111.
22. Connor, J. R., Snyder, B. S., Beard, J. L., Fine, R. E., and Mufson, E. J. (1992a). Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J. Neurosci. Res. 31, 327-335. doi: 10.1002/jnr.490310214.
23. Dewachter, I., Reverse, D., Caluwaerts, N., Ris, L., Kuiperi, C., Van den Haute, C., et al. (2002). Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J. Neurosci. 22, 3445-3453.
24. Duce, J. A., Tsatsanis, A., Cater, M. A., James, S. A., Robb, E., Wikhe, K., et al. (2010). Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857-867. doi: 10.1016/j.cell.2010.08.014.
25. El Tannir El Tayara, N., Delatour, B., Le Cudennec, C., Guegan, M., Volk, A., and Dhenain, M. (2006). Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 22, 199-208. doi: 10.1016/j.nbd.2005.10.013.
26. Gallagher, J. J., Finnegan, M. E., Grehan, B., Dobson, J., Collingwood, J. F., and Lynch, M. A. (2012). Modest amyloid deposition is associated with iron dysregulation, microglial activation, and oxidative stress. J. Alzheimers Dis. 28, 147-161. doi: 10.3233/JAD-2011-110614.
27. Gerlach, M., Ben-Shachar, D., Riederer, P., and Youdim, M. B. (1994). Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63, 793-807. doi: 10.1046/j.1471-4159.1994.63030793.x.
28. Ghribi, O., Golovko, M. Y., Larsen, B., Schrag, M., and Murphy, E. J. (2006). Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets. J. Neurochem. 99, 438-449. doi: 10.1111/j.1471-4159.2006.04079.x.
29. Gordon, M. N., Holcomb, L. A., Jantzen, P. T., DiCarlo, G., Wilcock, D., Boyett, K. W., et al. (2002). Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse. Exp. Neurol. 173, 183-195. doi: 10.1006/exnr.2001.7754.
30. Grundke-Iqbal, I., Fleming, J., Tung, Y. C., Lassmann, H., Iqbal, K., and Joshi, J. G. (1990). Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol. 81, 105-110. doi: 10.1007/BF00334497.
31. Guo, C., Wang, P., Zhong, M. L., Wang, T., Huang, X. S., Li, J. Y., et al. (2013b). Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain. Neurochem. Int. 62, 165-172. doi: 10.1016/j.neuint.2012.12.005.
32. Guo, C., Wang, T., Zheng, W., Shan, Z. Y., Teng, W. P., and Wang, Z. Y. (2013a). Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease. Neurobiol. Aging 34, 562-575. doi: 10.1016/j.neurobiolaging.2012.05.009.
33. Hajos, M., Morozova, E., Siok, C., Atchison, K., Nolan, C. E., Riddell, D., et al. (2013). Effects of the gamma-secretase inhibitor semagacestat on hippocampal neuronal network oscillation. Front. Pharmacol. 4:72. doi: 10.3389/fphar.2013.00072.
34. Han, J., Day, J. R., Connor, J. R., and Beard, J. L. (2002). H and L ferritin subunit mRNA expression differs in brains of control and iron-deficient rats. J. Nutr. 132, 2769-2774.
35. Hardy, J., and Allsop, D. (1991). Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12, 383-388. doi: 10.1016/0165-6147(91)90609-V.
36. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. doi: 10.1126/science.1072994.
37. Harman, D. (2006). Alzheimer's disease pathogenesis: role of aging. Ann. N.Y. Acad. Sci. 1067, 454-460. doi: 10.1196/annals.1354.065.
38. Huang, X., Atwood, C. S., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., et al. (1999). The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38, 7609-7616. doi: 10.1021/bi990438f.
39. Jack, C. R. Jr., Garwood, M., Wengenack, T. M., Borowski, B., Curran, G. L., Lin, J., et al. (2004). In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn. Reson. Med. 52, 1263-1271. doi: 10.1002/mrm.20266.
40. Jankowsky, J. L., Slunt, H. H., Ratovitski, T., Jenkins, N. A., Copeland, N. G., and Borchelt, D. R. (2001). Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol. Eng. 17, 157-165. doi: 10.1016/S1389-0344(01)00067-3.
41. Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., and Youdim, M. B. (1990). Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J. Neural Transm. Park. Dis. Dement. Sect. 2, 327-340. doi: 10.1007/BF02252926.
42. Jiang, D., Li, X., Williams, R., Patel, S., Men, L., Wang, Y., et al. (2009). Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease. Biochemistry 48, 7939-7947. doi: 10.1021/bi900907a.
43. Kaneko, Y., Kitamoto, T., Tateishi, J., and Yamaguchi, K. (1989). Ferritin immunohistochemistry as a marker for microglia. Acta Neuropathol. 79, 129-136. doi: 10.1007/BF00294369.
44. Khan, A., Dobson, J. P., and Exley, C. (2006). Redox cycling of iron by Abeta42. Free Radic. Biol. Med. 40, 557-569. doi: 10.1016/j.freeradbiomed.2005.09.013.
45. Kienlen-Campard, P., Miolet, S., Tasiaux, B., and Octave, J. N. (2002). Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis. J. Biol. Chem. 277, 15666-15670. doi: 10.1074/jbc.M200887200.
46. Koenigsknecht, J., and Landreth, G. (2004). Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. J. Neurosci. 24, 9838-9846. doi: 10.1523/JNEUROSCI.2557-04.2004.
47. LeVine, S. M. (1991). Oligodendrocytes and myelin sheaths in normal, quaking and shiverer brains are enriched in iron. J. Neurosci. Res. 29, 413-419. doi: 10.1002/jnr.490290317.
48. LeVine, S. M. (1997). Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res. 760, 298-303. doi: 10.1016/S0006-8993(97)00470-8.
49. Lopes, K. O., Sparks, D. L., and Streit, W. J. (2008). Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity. Glia 56, 1048-1060. doi: 10.1002/glia.20678.
50. Lovell, M. A., and Markesbery, W. R. (2007). Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J. Neurosci. Res. 85, 3036-3040. doi: 10.1002/jnr.21346.
51. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., and Markesbery, W. R. (1998). Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47-52. doi: 10.1016/S0022-510X(98)00092-6.
52. Malm, T., Magga, J., and Koistinaho, J. (2012). Animal models of Alzheimer's Disease: utilization of transgenic Alzheimer's disease models in studies of amyloid beta clearance. Curr. Transl. Geriatr. Exp. Gerontol. Rep. 1, 11-20. doi: 10.1007/s13670-011-0004-z.
53. Maynard, C. J., Bush, A. I., Masters, C. L., Cappai, R., and Li, Q. X. (2005). Metals and amyloid-beta in Alzheimer's disease. Int. J. Exp. Pathol. 86, 147-159. doi: 10.1111/j.0959-9673.2005.00434.x.
54. Meadowcroft, M. D., Connor, J. R., Smith, M. B., and Yang, Q. X. (2009). MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice. J. Magn. Reson. Imaging 29, 997-1007. doi: 10.1002/jmri.21731.
55. Mehlhase, J., Gieche, J., Widmer, R., and Grune, T. (2006). Ferritin levels in microglia depend upon activation: modulation by reactive oxygen species. Biochim. Biophys. Acta 1763, 854-859. doi: 10.1016/j.bbamcr.2006.04.012.
56. Mengel, D., Roskam, S., Neff, F., Balakrishnan, K., Deuster, O., Gold, M., et al. (2013). Naturally occurring autoantibodies interfere with beta-amyloid metabolism and improve cognition in a transgenic mouse model of Alzheimer's disease 24 h after single treatment. Transl. Psychiatry 3, e236. doi: 10.1038/tp.2012.151.
57. Pekny, M., and Nilsson, M. (2005). Astrocyte activation and reactive gliosis. Glia 50, 427-434. doi: 10.1002/glia.20207.
58. Perry, G., Nunomura, A., Hirai, K., Zhu, X., Perez, M., Avila, J., et al. (2002). Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic. Biol. Med. 33, 1475-1479. doi: 10.1016/S0891-5849(02)01113-9.
59. Pimplikar, S. W. (2009). Reassessing the amyloid cascade hypothesis of Alzheimer's disease. Int. J. Biochem. Cell Biol. 41, 1261-1268. doi: 10.1016/j.biocel.2008.12.015.
60. Richards, J. G., Higgins, G. A., Ouagazzal, A. M., Ozmen, L., Kew, J. N., Bohrmann, B., et al. (2003). PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation. J. Neurosci. 23, 8989-9003.
61. Rogers, J. T., Bush, A. I., Cho, H. H., Smith, D. H., Thomson, A. M., Friedlich, A. L., et al. (2008). Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease. Biochem. Soc. Trans. 36(Pt 6), 1282-1287. doi: 10.1042/BST0361282.
62. Rottkamp, C. A., Raina, A. K., Zhu, X., Gaier, E., Bush, A. I., Atwood, C. S., et al. (2001). Redox-active iron mediates amyloid-beta toxicity. Free Radic. Biol. Med. 30, 447-450. doi: 10.1016/S0891-5849(00)00494-9.
63. Ryu, J., Girigoswami, K., Ha, C., Ku, S. H., and Park, C. B. (2008). Influence of multiple metal ions on beta-amyloid aggregation and dissociation on a solid surface. Biochemistry 47, 5328-5335. doi: 10.1021/bi800012e.
64. Sayre, L. M., Perry, G., Harris, P. L., Liu, Y., Schubert, K. A., and Smith, M. A. (2000). In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J. Neurochem. 74, 270-279. doi: 10.1046/j.1471-4159.2000.0740270.x.
65. Sayre, L. M., Zagorski, M. G., Surewicz, W. K., Krafft, G. A., and Perry, G. (1997). Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal. Chem. Res. Toxicol. 10, 518-526. doi: 10.1021/tx970009n.
66. Schmued, L. C., Stowers, C. C., Scallet, A. C., and Xu, L. (2005). Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res. 1035, 24-31. doi: 10.1016/j.brainres.2004.11.054.
67. Schubert, D., Soucek, T., and Blouw, B. (2009). The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide. Eur. J. Neurosci. 29, 1323-1334. doi: 10.1111/j.1460-9568.2009.06712.x.
68. Schwab, C., Hosokawa, M., and McGeer, P. L. (2004). Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Exp. Neurol. 188, 52-64. doi: 10.1016/j.expneurol.2004.03.016.
69. Siman, R., Reaume, A. G., Savage, M. J., Trusko, S., Lin, Y. G., Scott, R. W., et al. (2000). Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability. J. Neurosci. 20, 8717-8726. doi: 10.1016/s0197-4580(00)82329-5.
70. Smith, M. A., Harris, P. L., Sayre, L. M., and Perry, G. (1997). Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U.S.A. 94, 9866-9868. doi: 10.1073/pnas.94.18.9866.
71. Smith, M. A., Nunomura, A., Zhu, X., Takeda, A., and Perry, G. (2000). Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. Antioxid. Redox Signal. 2, 413-420. doi: 10.1089/15230860050192198.
72. Smith, M. A., Sayre, L. M., and Perry, G. (1996). Is Alzheimer's a disease of oxidative stress? Alzheimers Dis. Rev. 1, 63-67.
73. Telfer, J. F., and Brock, J. H. (2002). Expression of ferritin, transferrin receptor, and non-specific resistance associated macrophage proteins 1 and 2 (Nramp1 and Nramp2) in the human rheumatoid synovium. Ann. Rheum. Dis. 61, 741-744. doi: 10.1136/ard.61.8.741.
74. Thompson, K., Menzies, S., Muckenthaler, M., Torti, F. M., Wood, T., Torti, S. V., et al. (2003). Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. J. Neurosci. Res. 71, 46-63. doi: 10.1002/jnr.10463.
75. von Bernhardi, R., and Ramirez, G. (2001). Microglia-astrocyte interaction in Alzheimer's disease: friends or foes for the nervous system? Biol. Res. 34, 123-128. doi: 10.4067/S0716-97602001000200017.
76. Wadghiri, Y. Z., Hoang, D. M., Wisniewski, T., and Sigurdsson, E. M. (2012). In vivo magnetic resonance imaging of amyloid-beta plaques in mice. Methods Mol. Biol. 849, 435-451. doi: 10.1007/978-1-61779-551-0_30.
77. Wegiel, J., Imaki, H., Wang, K. C., Wronska, A., Osuchowski, M., and Rubenstein, R. (2003). Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice. Acta Neuropathol. 105, 393-402. doi: 10.1007/s00401-002-0660-3.
78. Wegiel, J., Wang, K. C., Imaki, H., Rubenstein, R., Wronska, A., Osuchowski, M., et al. (2001). The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Neurobiol. Aging 22, 49-61. doi: 10.1016/S0197-4580(00)00181-0.
79. Wegiel, J., Wang, K. C., Tarnawski, M., and Lach, B. (2000). Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation. Acta Neuropathol. 100, 356-364. doi: 10.1007/s004010000199.
80. Wengenack, T. M., Reyes, D. A., Curran, G. L., Borowski, B. J., Lin, J., Preboske, G. M., et al. (2011). Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain. Neuroimage 54, 113-122. doi: 10.1016/j.neuroimage.2010.08.033.
81. Wong, B. X., Tsatsanis, A., Lim, L. Q., Adlard, P. A., Bush, A. I., and Duce, J. A. (2014). beta-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin. PLoS ONE 9:e114174. doi: 10.1371/journal.pone.0114174.
82. Woodhouse, A., Vickers, J. C., Adlard, P. A., and Dickson, T. C. (2009). Dystrophic neurites in TgCRND8 and Tg2576 mice mimic human pathological brain aging. Neurobiol. Aging 30, 864-874. doi: 10.1016/j.neurobiolaging.2007.09.003.